Filing Flows

Filing Flows › Pulmonx (LUNG) › Guidance history

Pulmonx (LUNG) guidance history: what it guided and what it reported

Pulmonx gave guidance in 4 earnings releases on file since Apr 29, 2026. Its releases raised guidance once and lowered it once.

Revenue

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$90.0M–$92.0M (Apr 29, 2026) → reaffirmed $90.0M–$92.0M (Jul 29, 2026) → reaffirmed $90.0M–$92.0M (Oct 27, 2026)—to be reported—

Gross margin

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY202675.0% (Apr 29, 2026) → raised 76.0% (Jul 29, 2026) → raised 77.0% (Oct 27, 2026)—to be reported—

Operating expenses

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$113M–$115M (Apr 29, 2026) → lowered $109M–$111M (Jul 29, 2026) → lowered $108M–$109M (Oct 27, 2026)—to be reported—

Capital expenditures

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$100K (Nov 3, 2026)—to be reported—

The latest quarter

Pulmonx, Q3 2026: revenue $22.8M (+6% year over year), operating margin -32.8%, net loss $8.4M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.

Questions

Does Pulmonx beat its guidance?

Pulmonx gave guidance in 4 earnings releases on file since Apr 29, 2026. Its releases raised guidance once and lowered it once.

How often does Pulmonx raise guidance?

Its earnings releases raised guidance once and lowered it once since Apr 29, 2026.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.